Sunshine Biopharma Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Sunshine Biopharma Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Sunshine Biopharma Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $6.4M, a 14.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $6.4M +$801K +14.3% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $5.6M Dec 31, 2022 10-K 2023-04-04
Q3 2015 $2.87M Sep 30, 2015 10-Q 2015-11-04
Q4 2014 $3.26M +$2.16M +196% Dec 31, 2014 10-Q 2015-11-04
Q4 2013 $1.1M +$498K +83% Dec 31, 2013 10-K 2014-03-19
Q4 2012 $601K +$489K +440% Dec 31, 2012 10-K 2014-03-19
Q4 2011 $111K Dec 31, 2011 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.